RARE
NEGATIVE BIASUltragenyx Pharmaceutical Inc. · Healthcare
$23.28-2.63%LAST CLOSE
24H-2.63%
1W+3.70%
1M+4.82%
1Y-25.05%
Live Chart · RARE
1DNY TIME
BOGA Master Score
41.6
High conviction score
BOGA AI Model Projection
Strategic Observation Zone$22.56 - $23.40
Projected Growth Objective$25.93 - $27.78
Model Invalidation Level$20.10 - $21.16
Risk/Reward1.5:1
AD-S2 · 300×250 Sidebar
Technical Indicators
RSI (14)
58.8
Neutral
MACD
0.483
NEUTRAL
RVOL
0.64x
Normal
Trends
UP
UP
EMA Stack
Bearish
STABLE
BB Squeeze
LOW
MONITOR
Fundamentals & Margins
Market Cap
P/E Ratio
vs Sector: 25.0730915
FCF Yield
Gross Margin
Operating Margin
Net Margin
Sector Context
Benchmarked against
XLV
5D Performance
+1.3%
RARE is currently ranked in the top 20% of its sector based on BOGA Master Scores. It has outperformed XLV by 4.2% over the last 30 trading days.
Insider Activity (90D)
| Transaction | Shares | Net Direction |
|---|---|---|
| Buys | 0 | SELL |
| Sells | 10 |
Last Transaction: SELL 4683 shares

Share This Insight
Help others discover this score. Professional analysts share high-conviction data.
Share This Insight
Help others discover this score. Professional analysts share high-conviction data.